摘要
探究二价阳离子络合剂的抗凝剂在改良单克隆抗体俘获血小板抗原(MAIPA)法检测免疫性血小板减少症(ITP)患者血小板特异性自身抗体中的影响。分别留取ED-TA-K2和肝素钠抗凝的162例ITP患者标本,采用改良MAI-PA法检测血小板特异性自身膜糖蛋白IIbIIIa(GPIIbIIIa)和膜糖蛋白Ibα(GPIbα)。抗GPIIbIIIa抗体:单用EDTA-K2抗凝剂检出阳性77例,单用肝素钠抗凝剂检出阳性78例,双重检测阳性102例;抗GPIbα抗体:单用EDTA-K2抗凝剂检出阳性53例,单用肝素钠抗凝剂检出阳性51例,双重检测阳性72例。单一抗凝剂与双重抗凝剂比较差异有统计学意义(P<0.05)。二价阳离子络合剂的抗凝剂在改良MAIPA法检测ITP患者血小板特异性自身抗体中有一定影响,采用两种抗凝剂双重检测可提高自身抗体的检出率。
To investigate the influence of differet anticoagulant by modified monoclonal antibody immobilization of platelet antigen assay (MAIPA), on immune thrombocytopenia (ITP) platelet specific antibodies glycoprotein IIbI- IIα (GPIIbIIIa) and glycoprotein Ibct (GPIbct). Samples from ethylene diamine tetraacetie acid dipotassium (ED- TA-K2) and heparin anticoagulation patients were obtained. 162 ITP samples were detected by modified MAIPA platelet specific autoantibodies (GPIIb Ⅲ a and GPIbα ). Group of patients were detected. Single anticoagulants group and dual anticoagulants group differences are statistically significant in detection of GPIIbIIIa and GPIbα(P 〈 0.05 ). There is significant effect in detection of different anticoagulant detected ITP platelet specific antibodies on modified MAIPA. Adopting both anticoagulants to perform combined detection can improve ITP platelet specific antibodies.
出处
《安徽医科大学学报》
CAS
北大核心
2013年第7期832-834,共3页
Acta Universitatis Medicinalis Anhui
基金
安徽省自然科学基金项目(编号:1308085MH157)
安徽省国际科技合作计划项目(编号:10080703039)